U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Malignant tumor of urinary bladder

MedGen UID:
14150
Concept ID:
C0005684
Neoplastic Process
Synonyms: Bladder cancer; Urinary bladder cancer; Urinary Bladder Neoplasms
SNOMED CT: Malignant tumor of urinary bladder (399326009); Bladder cancer (399326009); Malignant neoplasm of urinary bladder (399326009); CA - Bladder cancer (399326009)
 
Genes (locations): FGFR3 (4p16.3); HRAS (11p15.5); KRAS (12p12.1); RB1 (13q14.2)
 
Monarch Initiative: MONDO:0001187
OMIM®: 109800
Orphanet: ORPHA157980

Definition

A primary or metastatic malignant neoplasm involving the bladder. [from NCI]

Clinical features

From HPO
Bladder neoplasm
MedGen UID:
594
Concept ID:
C0005695
Neoplastic Process
The presence of a neoplasm of the urinary bladder.
Transitional cell carcinoma of the bladder
MedGen UID:
76013
Concept ID:
C0279680
Neoplastic Process
The presence of a carcinoma of the urinary bladder with origin in a transitional epithelial cell.

Term Hierarchy

Professional guidelines

PubMed

Compérat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA
Lancet 2022 Nov 12;400(10364):1712-1721. Epub 2022 Sep 26 doi: 10.1016/S0140-6736(22)01188-6. PMID: 36174585
Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q
J Nanobiotechnology 2021 Nov 27;19(1):393. doi: 10.1186/s12951-021-01104-y. PMID: 34838048Free PMC Article
DeGeorge KC, Holt HR, Hodges SC
Am Fam Physician 2017 Oct 15;96(8):507-514. PMID: 29094888

Curated

UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Bladder Cancer, 2023

Recent clinical studies

Etiology

Matalliotaki C, Matalliotakis M, Zervou MI, Trivli A, Matalliotakis I, Mavromatidis G, Spandidos DA, Albertsen HM, Chettier R, Ward K, Goulielmos GN
Mol Med Rep 2018 Dec;18(6):5053-5057. Epub 2018 Oct 1 doi: 10.3892/mmr.2018.9521. PMID: 30272298Free PMC Article

Diagnosis

Matalliotaki C, Matalliotakis M, Zervou MI, Trivli A, Matalliotakis I, Mavromatidis G, Spandidos DA, Albertsen HM, Chettier R, Ward K, Goulielmos GN
Mol Med Rep 2018 Dec;18(6):5053-5057. Epub 2018 Oct 1 doi: 10.3892/mmr.2018.9521. PMID: 30272298Free PMC Article

Clinical prediction guides

Matalliotaki C, Matalliotakis M, Zervou MI, Trivli A, Matalliotakis I, Mavromatidis G, Spandidos DA, Albertsen HM, Chettier R, Ward K, Goulielmos GN
Mol Med Rep 2018 Dec;18(6):5053-5057. Epub 2018 Oct 1 doi: 10.3892/mmr.2018.9521. PMID: 30272298Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NICE, 2023
      UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023
    • NCCN, 2023
      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Bladder Cancer, 2023

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...